BioLargo subsidiary Clyra advances ViaCLYR evaluations with US health systems
BLGO•Clyra Medical is advancing clinical evaluations and approval processes for its FDA-cleared ViaCLYR wound irrigation solution at several US health systems. The solution has treated hundreds of patients since its March 2026 commercial launch, and the most advanced discussions involve a system with almost 20 hospitals and 200 clinics.
1. ViaCLYR evaluations
BioLargo subsidiary Clyra Medical is advancing ViaCLYR through clinical evaluations and approval processes at several US healthcare systems. The most advanced discussions involve a system operating almost 20 hospitals and 200 clinics; the solution has treated hundreds of patients since its March 2026 commercial launch.
